Search
Zhifei Biological: Clinical Trial Approval for Subsidiary's Adsorbed Tetanus Vaccine
3 week ago /
Read about 0 minute
Author：小编
Zhifei Lvzhu, a fully-owned subsidiary of Zhifei Biological, has secured approval from the National Medical Products Administration to commence clinical trials for its adsorbed tetanus vaccine. This vaccine, designed for tetanus prevention, employs column chromatography for antigen purification, yielding a higher purity and enhanced immunogenicity compared to conventional methods.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
